Quarterly report pursuant to Section 13 or 15(d)

Related Party Agreements (Narrative) (Details)

v3.23.2
Related Party Agreements (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jan. 06, 2023
Jan. 01, 2022
Jul. 22, 2016
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Related Party Transaction [Line Items]                
Common stock, shares issuable       0   0   187,134
Proceeds from debt issuance           $ 0 $ 30,000  
At the Market Offering [Member]                
Related Party Transaction [Line Items]                
Proceeds from issuance of common shares             $ 5,900  
Fortress Biotech, Inc [Member]                
Related Party Transaction [Line Items]                
Percentage of annual fees expense related to Management Services Agreement recorded in research and development expenses           50.00% 50.00%  
Percentage of annual fees expense related to Management Services Agreement recorded in general and administrative expenses           50.00% 50.00%  
Shares issued for services (in shares) 187,134              
Common stock, shares issuable       2,777   2,777    
Percentage of fully diluted equity   2.50% 2.50%          
Expenses from related party transaction       $ 100 $ 300      
Fortress Biotech, Inc [Member] | Research and development [Member]                
Related Party Transaction [Line Items]                
Expenses from related party transaction               $ 1,100
Fortress Biotech, Inc [Member] | General and administrative [Member]                
Related Party Transaction [Line Items]                
Expenses from related party transaction       $ 0 $ 100 $ 0 $ 900